Search

Search Constraints

You searched for: Author/Creator Kievit, W

Search Results

5. Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies. Issue 6 (14th July 2008)

7. Lengthening adalimumab dosing interval in quiescent Crohn's disease patients: protocol for the pragmatic randomised non-inferiority LADI study. Issue 5 (26th May 2020)

10. P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial. (30th January 2023)